Similar articles

• Irinotecan in small-cell lung cancer--Japanese trials.

  Fukuoka M, Masuda N, Kudoh S, Negoro S. Fukuoka M, et al. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):57-62. Oncology (Williston Park). 2000. PMID: 10981292 Review.
• [Role of irinotecan in the treatment of small cell carcinoma].

  Crinò L. Crinò L. Tumori. 2001 Nov-Dec;87(6):A35-7. Tumori. 2001. PMID: 11995707 Review. Italian. No abstract available.
• Irinotecan in the treatment of small cell lung cancer.

  Masuda N, Fukuoka M. Masuda N, et al. Expert Rev Anticancer Ther. 2001 Aug;1(2):187-95. doi: 10.1586/14737140.1.2.187. Expert Rev Anticancer Ther. 2001. PMID: 12113024 Review.
• Irinotecan in advanced lung cancer: focus on North American trials.

  Langer CJ. Langer CJ. Oncology (Williston Park). 2004 Jun;18(7 Suppl 4):17-28. Oncology (Williston Park). 2004. PMID: 15255164 Clinical Trial.
• Lung cancer--time to move on from chemotherapy.

  Carney DN. Carney DN. N Engl J Med. 2002 Jan 10;346(2):126-8. doi: 10.1056/NEJM200201103460211. N Engl J Med. 2002. PMID: 11784881 No abstract available.